µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
ºÐ·ù¾øÀ½
 
¸é¿ªÁ¶Àý Ç×¾ÏÁ¦(Immunomodulators)

´ÜÀÏÁ¦ ÃÑ 60°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
lenalidomide hemihydrate 20.70mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide hemihydrate 7.76mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide hemihydrate 2.59mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
elotuzumab 340mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
elotuzumab 440mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 10mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 15mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 25mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 5mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
atezolizumab 1200mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 20mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 7.5mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide anhydrous 2.5mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
daratumumab 20mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
lenalidomide hemihydrate 10.35mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
atezolizumab 840mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
daratumumab 1.8gÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Nivolumab 240mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
ciltacabtagene autoleucel 2.1-39 ¡¿ 10^6 cells/mL ºÐ·ùµÇÁö ¾Ê´Â ÇÔ·®´ÜÀ§ÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
tislelizumab 100mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
[3]
º¹ÇÕÁ¦ ÃÑ0°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
°Ë»ö°á°ú°¡ ¾ø½À´Ï´Ù.
 
ºñÆ®µå·¯±×ÀÎÆ÷